User profiles for Luis Caminal-Montero

Luis Caminal-Montero

Medicina Interna. HUCA. Oviedo. Spain.
Verified email at sespa.princast.es
Cited by 2104

[PDF][PDF] A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility

…, JB Díaz-López, L Caminal-Montero… - The American Journal of …, 2015 - cell.com
We conducted a large-scale genetic analysis on giant cell arteritis (GCA), a polygenic
immune-mediated vasculitis. A case-control cohort, comprising 1,651 case subjects with GCA and …

[PDF][PDF] A genome-wide association study identifies risk alleles in plasminogen and P4HA2 associated with giant cell arteritis

…, JL Callejas, L Caminal-Montero… - The American Journal of …, 2017 - cell.com
Giant cell arteritis (GCA) is the most common form of vasculitis in individuals older than 50
years in Western countries. To shed light onto the genetic background influencing …

[HTML][HTML] A pathogenic IFNα, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients

P López, J Rodríguez-Carrio, L Caminal-Montero… - Scientific reports, 2016 - nature.com
This study aims to analyze in depth the role of IFNα in the upregulation of BLyS in different
leukocyte populations and the possible relationship of these molecules with IL-17 and other …

Clinical associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies: diagnostic utility of their separate detection

…, J Gómez, E Escanlar, L Caminal-Montero… - …, 2013 - Taylor & Francis
Clinical associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies are not yet fully
established. In order to analyse the diagnostic utility of their separate detection, we …

[HTML][HTML] Off-label use of rituximab for systemic lupus erythematosus in Europe

…, I Bultink, JLC Rubio, L Caminal-Montero… - Lupus science & …, 2016 - lupus.bmj.com
Objectives Rituximab (RTX) is a biological treatment used off-label in patients with systemic
lupus erythematosus (SLE). This survey aimed to investigate the off-label use of RTX in …

[HTML][HTML] Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label

…, J Rascón, L Caminal-Montero… - Arthritis research & …, 2011 - Springer
Introduction The purpose of this observational study was to analyze the rates, characteristics
and associated risk factors of severe infections in patients with systemic autoimmune …

[HTML][HTML] Prognostic factors of death in 151 adults with hemophagocytic syndrome: etiopathogenically driven analysis

…, AA Aguilar, L Caminal-Montero… - … : Innovations, Quality & …, 2018 - Elsevier
Objective To characterize the etiologies and clinical features at diagnosis of patients with
hemophagocytic lymphohistiocytosis (HLH) and correlate these baseline features with survival …

Senescent profile of angiogenic T cells from systemic lupus erythematosus patients

…, A Martínez-Zapico, L Caminal-Montero… - Journal of Leucocyte …, 2016 - academic.oup.com
The chronic inflammatory environment associated with systemic lupus erythematosus can
lead to an accelerated immunosenescence responsible for the endothelial damage and …

[HTML][HTML] Common and specific associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies in systemic lupus erythematosus

A Menéndez, J Gómez, L Caminal-Montero… - The Scientific World …, 2013 - hindawi.com
Little information exists about the association of anti-SSA/Ro60 and anti-Ro52/TRIM21 with
systemic lupus erytematosus (SLE) features. In this work, we analysed the associations of …

[HTML][HTML] COVID-19 Associated Pulmonary Aspergillosis (CAPA): Hospital or Home Environment as a Source of Life-Threatening Aspergillus fumigatus Infection?

…, S Melón-García, L Caminal-Montero… - Journal of Fungi, 2022 - mdpi.com
Most cases of invasive aspergillosis are caused by Aspergillus fumigatus, whose conidia
are ubiquitous in the environment. Additionally, in indoor environments, such as houses or …